Literature DB >> 12457968

Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus.

Ruth H Florese1, Motoko Nagano-Fujii, Yasuhiro Iwanaga, Rachmat Hidajat, Hak Hotta.   

Abstract

Possible inhibitory effects of hepatitis C virus (HCV) proteins on cellular protein synthesis were analyzed using transient expression system. The core protein, the nonstructural protein 4A (NS4A) and NS4B, but not NS3, NS5A or NS5B, inhibited p21/Waf1 expression post-transcriptionally. Further analysis revealed that the inhibition by NS4A and NS4B was mediated at least partly, if not entirely, at the translation level. NS4A-mediated translational inhibition was counteracted to some extent by NS3 co-expressed either in trans or cis. Co-expression of NS4A and NS4B exerted an additive effect on the translational inhibition. The N-terminal two-thirds of NS4A (amino acids 1-40) was shown to be involved in the translational inhibition. We also tested possible inhibitory effects of NS4A and NS4B on synthesis of other cellular proteins in parallel with p21/Waf1. NS4A and NS4B inhibited p21/Waf1 most strongly, followed by RNase L, p53, a C-terminally truncated form of CREB-RP and 2'-5' oligoadenylate synthetase. p21/Waf1, RNase L and p53 are known to have the PEST (proline-glutamic acid-serine-threonine) motif with relatively high scores in their sequences and considered to be sensitive to intracellular degradation. Taken together, our results suggest that NS4A and NS4B each mediate translational inhibition and, probably, increased degradation of certain cellular proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457968     DOI: 10.1016/s0168-1702(02)00146-6

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  18 in total

1.  The acidic domain of hepatitis C virus NS4A contributes to RNA replication and virus particle assembly.

Authors:  Tung Phan; Andrew Kohlway; Peniel Dimberu; Anna Marie Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

2.  Hepatitis C virus RNA replication and virus particle assembly require specific dimerization of the NS4A protein transmembrane domain.

Authors:  Andrew Kohlway; Nathan Pirakitikulr; Francisco N Barrera; Olga Potapova; Donald M Engelman; Anna M Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

Review 3.  Molecular targeted therapy for hepatocellular carcinoma: current and future.

Authors:  Jung Woo Shin; Young-Hwa Chung
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

Review 4.  Involvement of regucalcin as a suppressor protein in human carcinogenesis: insight into the gene therapy.

Authors:  Masayoshi Yamaguchi
Journal:  J Cancer Res Clin Oncol       Date:  2014-09-18       Impact factor: 4.553

5.  Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein.

Authors:  Zhengxian Gu; Jason D Graci; Frederick C Lahser; Jamie J Breslin; Stephen P Jung; James H Crona; Patricia McMonagle; Ellen Xia; Shaotang Liu; Gary Karp; Jin Zhu; Song Huang; Amin Nomeir; Marla Weetall; Neil G Almstead; Stuart W Peltz; Xiao Tong; Robert Ralston; Joseph M Colacino
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

6.  ACH-806, an NS4A antagonist, inhibits hepatitis C virus replication by altering the composition of viral replication complexes.

Authors:  Wengang Yang; Yongnian Sun; Xiaohong Hou; Yongsen Zhao; Joanne Fabrycki; Dawei Chen; Xiangzhu Wang; Atul Agarwal; Avinash Phadke; Milind Deshpande; Mingjun Huang
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

7.  An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication.

Authors:  Menashe Elazar; Ping Liu; Charles M Rice; Jeffrey S Glenn
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Allelic variation in the hepatitis C virus NS4B protein dramatically influences RNA replication.

Authors:  Keril J Blight
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

9.  Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B.

Authors:  Jodi Dufner-Beattie; Andrew O'Guin; Stephanie O'Guin; Aaron Briley; Bin Wang; Jennifer Balsarotti; Robert Roth; Gale Starkey; Urszula Slomczynska; Amine Noueiry; Paul D Olivo; Charles M Rice
Journal:  Antimicrob Agents Chemother       Date:  2014-04-07       Impact factor: 5.191

10.  Hepatitis C virus NS4B carboxy terminal domain is a membrane binding domain.

Authors:  Jolanda M P Liefhebber; Bernd W Brandt; Rene Broer; Willy J M Spaan; Hans C van Leeuwen
Journal:  Virol J       Date:  2009-05-25       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.